Correspondence 0001104659-23-059209 from AEON Biopharma, Inc. (AEON) (CIK 0001837607) (AEON)
AEON Biopharma, Inc. (AEON) (CIK 0001837607)
Date: May 11, 2023 · CIK: 0001837607 · Accession: 0001104659-23-059209
AI Filing Summary & Sentiment
File numbers found in text: 333-269006
Letter
VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences Attention: Tracie Mariner, Kevin Vaughn, Cindy Polynice and Joe McCann Re: Priveterra Acquisition Corp. Registration Statement on Form S-4 File No. 333-269006
Dear Ms. Mariner, Mr. Vaughn, Ms. Polynice and Mr. McCann:
In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-4 (Registration No. 333-269006) (the “Registration Statement”) of Priveterra Acquisition Corp. (the “Company”). We respectfully request that the Registration Statement become effective as of 4:00 p.m., Washington, D.C. time, on May 12, 2023, or as soon as practicable thereafter.
Please do not hesitate to contact W. Soren Kreider IV of Davis Polk & Wardwell LLP at (212) 450-4387, or w.soren.kreider @davispolk.com with any questions or comments with respect to this letter.
Thank you for your assistance in this matter.
[Signature Page Follows]
Very truly yours,
Priveterra Acquisition Corp.
Show Raw Text
CORRESP
1
filename1.htm
Priveterra Acquisition Corp.
300 SE 2nd Street, Suite 600
Fort Lauderdale, Florida 33301
May 11, 2023
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E., Washington, D.C.
20549
Attention: Tracie Mariner, Kevin Vaughn, Cindy Polynice and Joe McCann
Re: Priveterra Acquisition Corp.
Registration Statement on Form S-4
File No. 333-269006
Dear Ms. Mariner, Mr. Vaughn, Ms. Polynice and
Mr. McCann:
In accordance with Rule 461
under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form
S-4 (Registration No. 333-269006) (the “Registration Statement”) of Priveterra Acquisition Corp. (the “Company”).
We respectfully request that the Registration Statement become effective as of 4:00 p.m., Washington, D.C. time, on May 12, 2023, or as
soon as practicable thereafter.
Please do not hesitate to
contact W. Soren Kreider IV of Davis Polk & Wardwell LLP at (212) 450-4387, or w.soren.kreider @davispolk.com with any questions or
comments with respect to this letter.
Thank you for your assistance in this matter.
[Signature Page Follows]
Very truly yours,
Priveterra Acquisition Corp.
By:
/s/ Oleg Grodnensky
Oleg Grodnensky
Chief Operating Officer
cc: W. Soren Kreider IV, Davis Polk & Wardwell LLP
Lee Hochbaum, Davis Polk & Wardwell
LLP
B. Shayne Kennedy, Latham & Watkins
LLP
J. Ross McAloon, Latham & Watkins
LLP